Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof

Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof

US Patent 9169199 · Granted Oct 27, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for facilitating real-time analytics2022
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Systems and methods for facilitating real-time analytics2020
Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use a2020
Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-ass2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orp2020
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of ROR2019
Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as ago2019
N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses th2019
Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamm2019